Disclosures for "Clinical Features and Outcomes of Central Nervous System Tumors with NTRK Gene Fusions"
-
Dr. Amir Yazdani has nothing to disclose.
-
Dr. Lamoureux has nothing to disclose.
-
Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks. The institution of Dr. Fisher has received research support from AstraZeneca/Alexion. The institution of Dr. Fisher has received research support from Array BioPharma.
-
Dr. Lemelle has received research support from Fondation nuovo Soldati. Dr. Lemelle has received research support from Fondation Servier.
-
Dr. Pfaff has nothing to disclose.
-
Prof. Pfister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioskryb. Prof. Pfister has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for PMC. Prof. Pfister has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Orbach has nothing to disclose.
-
Dr. Raskin has nothing to disclose.
-
Dr. Drilon has received personal compensation for serving as an employee of 14ner/Elevation Oncology, Amgen, Anheart Therapeutics, Abbvie, ArcherDX, AstraZeneca, Bayer, Beigene, BergenBio, Blueprint Medicines, Boundless Bio, BMS, Chugai Pharmaceutical, EcoR1, EMD Serono, Entos, Exelixis, Helsinn, Hengrui Therapeutics, Ignyta/Genentech/Roche, Innocare, Janssen, Loxo/Lilly, Merus, Monopteros, MonteRosa, Novartis, Nuvalent, Pfizer, Prelude, Regeneron, Repare RX, Takeda/Ariad/Millenium, Treeline Bio, TP Therapeutics, Tyra Biosciences, Verastem, Zymeworks. Dr. Drilon has received personal compensation for serving as an employee of Answers in CME, Applied Pharmaceutical Science, Inc, AXIS, Clinical Care Options, Doc Congress, EPG Health, Harborside Nexus, I3 Health, Imedex, Liberum, Medendi, Medscape, Med Learning, MedTalks, MJH Life Sciences, MORE Health, Ology, OncLive, Paradigm, Peerview Institute, PeerVoice, Physicians Education Resources, Projects in Knowledge, Resources, Remedica Ltd , Research to Practice, RV More, Springer Healthcare, Targeted Oncology, TouchIME, WebMD. Dr. Drilon has stock in mBrace, Treeline. Dr. Drilon has received publishing royalties from a publication relating to health care. Dr. Drilon has a non-compensated relationship as a PI of Industry Trial (Associated Research to Institution) with Foundation Medicine, Teva, Taiho, GlaxSmithKlein, PharmaMar that is relevant to AAN interests or activities.
-
Dr. Zapotocky has nothing to disclose.
-
Dr. Tabori has nothing to disclose.
-
Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier.
-
Dr. Erker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
-
Prof. Gottardo has received research support from Perth Children's Hospital Foundation Stan Perron Charitable Foundation Chair in Paediatric Oncology & Haematology.
-
Prof. Ziegler has received personal compensation in the range of $0-$499 for serving as a Consultant for Medison Pharma. Prof. Ziegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Ziegler has received personal compensation in the range of $0-$499 for serving as an Expert Witness for The Law Office of Conrad Curry. Prof. Ziegler has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lex Medicus.
-
Dr. Lindsay has nothing to disclose.
-
Dr. Hoffman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Children's Oncology Group. Dr. Hoffman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Pediatric Brain Tumor Consoritum. Dr. Hoffman has received personal compensation in the range of $500-$4,999 for serving as a Advisory board member with Day One Biopharmaceuticals.
-
Dr. LASSALETTA ATIENZA has nothing to disclose.
-
Prof. jabado has nothing to disclose.
-
Dr. COLEMAN has nothing to disclose.
-
The institution of Dr. Mueller has received research support from BMS, Regeneron, Novartis, Chimerix, Kazia, Blueprint, Sonalasence, DayOne, Pfizer, Gilead.
-
The institution of Dr. Robison has received research support from Pfizer.
-
Dr. Geoerger has nothing to disclose.
-
Dr. Moertel has received personal compensation for serving as an employee of OX2 Therapeutics. Dr. Moertel has received personal compensation for serving as an employee of Alexion . Dr. Moertel has received personal compensation for serving as an employee of Springworks. Dr. Moertel has stock in OX2 Therapeutics. Dr. Moertel has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Clarke has nothing to disclose.
-
Dr. Resnick has nothing to disclose.
-
Mrs. Alves has nothing to disclose.
-
Prof. DOZ has received publishing royalties from a publication relating to health care.
-
Dr. Laetsch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advanced Microbubbles. Dr. Laetsch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AI Therapeutics. Dr. Laetsch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITM Oncologics. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Laetsch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO. The institution of Dr. Laetsch has received research support from Pfizer. The institution of Dr. Laetsch has received research support from Bayer. The institution of Dr. Laetsch has received research support from Lilly. The institution of Dr. Laetsch has received research support from US Department of Defense. The institution of Dr. Laetsch has received research support from National Cancer Institute. The institution of Dr. Laetsch has received research support from Stand Up to Cancer. The institution of Dr. Laetsch has received research support from Alex Lemonade Stand Foundation.
-
Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer. The institution of Dr. Perreault has received research support from Novartis. The institution of Dr. Perreault has received research support from Rocher.